MicroRNAs as regulators of prostate cancer metastasis
- Divya Bhagirath,
- Thao Ly Yang,
- Rajvir Dahiya,
- Sharanjot Saini(corresponding author)
- VA Medical Center
Scholary Output:
Chapter in Book/Report/Conference proceeding
Chapter
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Prostate cancer causes significant morbidity in men and metastatic disease is a major cause of cancer related deaths. Prostate metastasis is controlled by various cellular intrinsic and extrinsic factors, which are often under the regulatory control of various metastasis-associated genes. Given the dynamic nature of metastatic cancer cells, the various factors controlling this process are themselves regulated by microRNAs which are small non-coding RNAs. Significant research work has shown differential microRNA expression in primary and metastatic prostate cancer suggesting their importance in prostate pathogenesis. We will review the roles of different microRNAs in controlling the various steps in prostate metastasis.
Publication Information
Output type
Scholary Output:
Chapter in Book/Report/Conference proceeding
Chapter
Original language
English (US)Pages from-to (Number of pages)
Pages 83-100 (18 pages)Publication milestones
- Published - 2018
Publication status
Published - 2018
Publisher
Springer New York LLCPublication series
- Publication series name: Advances in Experimental Medicine and Biology
ISSN (Print): 0065-2598
ISSN (Electronic): 2214-8019
Volume: 1095
Publication IDs
- Scopus: 85053796343
- PubMed: 30229550
Host publication title
Advances in Experimental Medicine and BiologyPublication metrics
Metrics
SciVal
citations
6
SciVal
FWCI
2.02
SciVal
Author count
4
SciVal
Paper percentile
70
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Captures
14
Citation count
14
Funding Details
Acknowledgements We thank Dr. Roger Erickson for his support with preparation of the manuscript. Research in authors’ lab is supported by the National Cancer Institute at the NIH (Grant Number RO1CA177984).
FundersFunding number
NIH
RO1CA177984
NCI
-